Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Construction in Progress: 2012-2013

  • Ani Pharmaceuticals' Construction in Progress was N/A to $197,948 in Q3 2013 from the same period last year, while for Sep 2013 it was $197,948, marking a year-over-year change of. This contributed to the annual value of $208,069 for FY2012, which is N/A change from last year.
  • According to the latest figures from Q3 2013, Ani Pharmaceuticals' Construction in Progress is $197,948, which was up 12.29% from $176,276 recorded in Q2 2013.
  • Over the past 5 years, Ani Pharmaceuticals' Construction in Progress peaked at $208,069 during Q4 2012, and registered a low of $176,276 during Q2 2013.
  • Over the past 2 years, Ani Pharmaceuticals' median Construction in Progress value was $197,948 (recorded in 2013), while the average stood at $194,098.